Key facts
- This page summarizes William H. Shrank's Form 4 filing for HUMANA INC (HUM).
- 0 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2022, 09:52.
William H. Shrank - 05 Aug 2022 Form 4 Insider Report for HUMANA INC (HUM)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- HUM
- Reported as of
- 05 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Aug 2022, 09:52:17 UTC
- Prior SEC filing
- 03 May 2022
- Next SEC filing
- 14 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- William H. Shrank
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William H. Shrank filed Form 4 for HUMANA INC (HUM) on 05 Aug 2022.
Change
- Previous filing in this sequence was filed on 03 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,294
- Date
- 05 Aug 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,842
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 6,842
- Exercise price
- $248.00
- Footnotes
- F1
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,372
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 5,372
- Exercise price
- $350.79
- Footnotes
- F2
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,057
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 4,057
- Exercise price
- $376.61
- Footnotes
- F3
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,165
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,165
- Exercise price
- $425.06
- Footnotes
- F4
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 357
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 357
- Exercise price
- Footnotes
- F5, F6
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 658
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 658
- Exercise price
- Footnotes
- F5, F7
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 873
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 873
- Exercise price
- Footnotes
- F5, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
William H. Shrank is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 8 footnotes
Footnote F1
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22.
Footnote F2
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
Footnote F3
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
Footnote F4
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
Footnote F5
Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Footnote F6
Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
Footnote F7
Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
Footnote F8
Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.